Apr 30, 2019
Donna Shalala- Amount
- $1,001 to $15,000
- Filed
- Apr 27, 2020
Congress ticker disclosure profile
As of August 1 at 11:20 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference DBD. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
5
Disclosed ranges
$40K
Most active member desks
6 sells vs 5 buys
Latest trade Apr 30, 2019
Apr 30, 2019
Donna ShalalaMar 6, 2019
Donna ShalalaNov 7, 2017
Kenneth R. BuckOct 27, 2017
Kenneth R. BuckJul 14, 2017
Thad CochranMar 13, 2017
Thad CochranMar 8, 2017
Thad CochranFeb 1, 2016
Thomas MacarthurJan 19, 2016
Thomas MacarthurDec 16, 2015
Thomas MacarthurAug 27, 2014
Lois Frankel| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Apr 30, 2019 | Donna Shalala | Sell | $1,001 to $15,000 | Apr 27, 2020 | Open card |
| Mar 6, 2019 | Donna Shalala | Buy | $1,001 to $15,000 | Apr 27, 2020 | Open card |
| Nov 7, 2017 | Kenneth R. Buck | Sell | Receipt pending ingestion | Dec 11, 2017 | Open card |
| Oct 27, 2017 | Kenneth R. Buck | Buy | Receipt pending ingestion | Nov 2, 2017 | Open card |
| Jul 14, 2017 | Thad Cochran | Sell | Receipt pending ingestion | Aug 8, 2017 | Receipt pending ingestion |
| Mar 13, 2017 | Thad Cochran | Buy | Receipt pending ingestion | Apr 6, 2017 | Receipt pending ingestion |
| Mar 8, 2017 | Thad Cochran | Buy | Receipt pending ingestion | Apr 6, 2017 | Receipt pending ingestion |
| Feb 1, 2016 | Thomas Macarthur | Sell | $1,001 to $15,000 | Mar 3, 2016 | Open card |
| Jan 19, 2016 | Thomas Macarthur | Buy | $1,001 to $15,000 | Feb 6, 2016 | Open card |
| Dec 16, 2015 | Thomas Macarthur | Sell | $1,001 to $15,000 | Jan 6, 2016 | Open card |
| Aug 27, 2014 | Lois Frankel | Sell | Receipt pending ingestion | Sep 23, 2014 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 5 of 11 filed rows include disclosed amount ranges (45%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.